TP53 and cancer: We have optimized this technology in zebrafish to generate cancer-relevant point mutants in the tp53 gene (Prykhozhij et al., 2018b) and have reviewed other studies which applied similar techniques to introduce specific knock-in mutations (Prykhozhij and Berman, 2018).